ABSTRACT
Transdiagnostic cognitive-behavioral treatments for emotional disorders are a new approach that empirically supported. Despite this most of the researches in this field have no control group and so there is a little information about comparing of the effect of transdiagnostic approach to others. The current study was compared transdiagnostic with cognitive-behavior therapy on patients with depression and anxiety disorders. This study was a pretest-post test randomized control trial. A diagnostically heterogeneous clinical sample of 23 patients with a principal depression and anxiety disorders that randomly assigned in two groups and participated in eight sessions. Participants were recruited from clinical psychology and psychiatry clinics of Taleghani hospital, Tehran, Iran. Beck Depression Inventory [BDI-II], Beck Anxiety Inventory [BAI], and Quality of life Scale [IRQL] were completed pre and post intervention by participants. The results were analyzed by dependent sample t-test and analyses of covariance [ANCOVA]. Data analyses showed that transdiagnostic therapy was effective for decreasing anxiety and depression symptoms, and have more effect for anxiety in comparing to cognitive-behavior therapy. Transdiagnostic therapy was confirmed in decreasing depressive and anxiety symptoms and improving quality of life in patients with depression and anxiety disorders and transdiagnostic therapy was more effective than cognitive-behavior therapy for decrease anxiety symptoms
ABSTRACT
The goal of this study was to examine the construct validity of the diagnostic and statistical manual of mental disorder-5 [DSM-5] conceptual model of antisocial and borderline personality disorders [PDs]. More specifically, the aim was to determine whether the DSM-5 five-factor structure of pathological personality trait domains replicated in an independently collected sample that differs culturally from the derivation sample. This study was on a sample of 346 individuals with antisocial [n = 122] and borderline PD [n = 130], and nonclinical subjects [n = 94]. Participants randomly selected from prisoners, out-patient, and in-patient clients. Participants were recruited from Tehran prisoners, and clinical psychology and psychiatry clinics of Razi and Taleghani Hospital, Tehran, Iran. The SCID-II-PQ, SCID-II, DSM-5 Personality Trait Rating Form [Clinician's PTRF] were used to diagnosis of PD and to assessment of pathological traits. The data were analyzed by exploratory factor analysis. Factor analysis revealed a 5-factor solution for DSM-5 personality traits. Results showed that DSM-5 has adequate construct validity in Iranian sample with antisocial and borderline PDs. Factors similar in number with the other studies, but different in the content. Exploratory factor analysis revealed five homogeneous components of antisocial and borderline PDs. That may represent personality, behavioral, and affective features central to the disorder. Furthermore, the present study helps understand the adequacy of DSM-5 dimensional approach to evaluation of personality pathology, specifically on Iranian sample